VIVUS (VVUS) Cash Flow Statement

Click line-items for a historical chart and %

Net loss from continuing operations
Depreciation	823K
Share-based compensation expense	1.74M
Inventories	2.34M
Prepaid expenses and other assets	4.21M
Accounts payable	-620K
Accrued research and clinical expenses
Accrued employee compensation and benefits
Accrued and other liabilities	-7.23M
Net cash used for operating activities from continuing operations	48.59M
Net cash (used for) provided by operating activities from discontinued operations
Net cash used for operating activities
Property and equipment purchases	0
Investment purchases
Proceeds from sale/maturity of securities
Net cash provided by investing activities from continuing operations	16.49M
Net cash used for investing activities from discontinued operations
Net cash provided by investing activities
Net proceeds from exercise of common stock options
Sale of common stock through employee stock purchase plan
Net cash provided by financing activities from continuing operations	-6.33M
Net cash used for financing activities from discontinued operations
Net cash provided by financing activities
NET DECREASE IN CASH AND CASH EQUIVALENTS	58.74M
Beginning of period	95.4M
End of period	154.14M

Entities mentioned with VVUS

View All Entities